BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22851182)

  • 1. Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production.
    Wanngren J; Ottervald J; Parpal S; Portelius E; Strömberg K; Borgegård T; Klintenberg R; Juréus A; Blomqvist J; Blennow K; Zetterberg H; Lundkvist J; Rosqvist S; Karlström H
    J Biol Chem; 2012 Sep; 287(39):32640-50. PubMed ID: 22851182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms.
    Borgegard T; Juréus A; Olsson F; Rosqvist S; Sabirsh A; Rotticci D; Paulsen K; Klintenberg R; Yan H; Waldman M; Stromberg K; Nord J; Johansson J; Regner A; Parpal S; Malinowsky D; Radesater AC; Li T; Singh R; Eriksson H; Lundkvist J
    J Biol Chem; 2012 Apr; 287(15):11810-9. PubMed ID: 22334705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein.
    Sagi SA; Lessard CB; Winden KD; Maruyama H; Koo JC; Weggen S; Kukar TL; Golde TE; Koo EH
    J Biol Chem; 2011 Nov; 286(46):39794-803. PubMed ID: 21868380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID-based γ-secretase modulators do not bind to the amyloid-β polypeptide.
    Barrett PJ; Sanders CR; Kaufman SA; Michelsen K; Jordan JB
    Biochemistry; 2011 Nov; 50(47):10328-42. PubMed ID: 21995415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.
    Page RM; Gutsmiedl A; Fukumori A; Winkler E; Haass C; Steiner H
    J Biol Chem; 2010 Jun; 285(23):17798-810. PubMed ID: 20348104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-targeting gamma-secretase modulators.
    Kukar TL; Ladd TB; Bann MA; Fraering PC; Narlawar R; Maharvi GM; Healy B; Chapman R; Welzel AT; Price RW; Moore B; Rangachari V; Cusack B; Eriksen J; Jansen-West K; Verbeeck C; Yager D; Eckman C; Ye W; Sagi S; Cottrell BA; Torpey J; Rosenberry TL; Fauq A; Wolfe MS; Schmidt B; Walsh DM; Koo EH; Golde TE
    Nature; 2008 Jun; 453(7197):925-9. PubMed ID: 18548070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase.
    Czirr E; Cottrell BA; Leuchtenberger S; Kukar T; Ladd TB; Esselmann H; Paul S; Schubenel R; Torpey JW; Pietrzik CU; Golde TE; Wiltfang J; Baumann K; Koo EH; Weggen S
    J Biol Chem; 2008 Jun; 283(25):17049-54. PubMed ID: 18426795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
    Crump CJ; Johnson DS; Li YM
    Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain.
    Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Golde TE; Koo EH
    J Biol Chem; 2003 Aug; 278(33):30748-54. PubMed ID: 12777371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTF1-51, a truncated carboxyl-terminal fragment of amyloid precursor protein, suppresses the effects of Aβ42-lowering γ-secretase modulators.
    Watahiki H; Yagishita S; Futai E; Ishiura S
    Neurosci Lett; 2012 Sep; 526(2):96-9. PubMed ID: 22940081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. γ-Secretase modulator in Alzheimer's disease: shifting the end.
    Xia W; Wong ST; Hanlon E; Morin P
    J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.
    Richter L; Munter LM; Ness J; Hildebrand PW; Dasari M; Unterreitmeier S; Bulic B; Beyermann M; Gust R; Reif B; Weggen S; Langosch D; Multhaup G
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14597-602. PubMed ID: 20679249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processing.
    Weber TA; Lundkvist J; Wanngren J; Kvartsberg H; Jin S; Larssen P; Wu D; Oliveira DV; Minta K; Brinkmalm G; Zetterberg H; Blennow K; Nordvall G; Winblad B; Portelius E; Karlström H
    J Cell Mol Med; 2022 Feb; 26(3):880-892. PubMed ID: 34931449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex relationships between substrate sequence and sensitivity to alterations in γ-secretase processivity induced by γ-secretase modulators.
    Jung JI; Ran Y; Cruz PE; Rosario AM; Ladd TB; Kukar TL; Koo EH; Felsenstein KM; Golde TE
    Biochemistry; 2014 Apr; 53(12):1947-57. PubMed ID: 24620716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP).
    Lessard CB; Cottrell BA; Maruyama H; Suresh S; Golde TE; Koo EH
    PLoS One; 2015; 10(12):e0144758. PubMed ID: 26678856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid X receptor-alpha mediates (R )-flurbiprofen's effect on the levels of Alzheimer's beta-amyloid.
    You X; Zhang YW; Chen Y; Huang X; Xu R; Cao X; Chen J; Liu Y; Zhang X; Xu H
    J Neurochem; 2009 Oct; 111(1):142-9. PubMed ID: 19659691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Abeta42 responses to low potency gamma-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds.
    Kretner B; Fukumori A; Gutsmiedl A; Page RM; Luebbers T; Galley G; Baumann K; Haass C; Steiner H
    J Biol Chem; 2011 Apr; 286(17):15240-51. PubMed ID: 21357415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.
    Lessard CB; Rodriguez E; Ladd TB; Minter LM; Osborne BA; Miele L; Golde TE; Ran Y
    Alzheimers Res Ther; 2020 May; 12(1):61. PubMed ID: 32430033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
    Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
    Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The large hydrophilic loop of presenilin 1 is important for regulating gamma-secretase complex assembly and dictating the amyloid beta peptide (Abeta) Profile without affecting Notch processing.
    Wanngren J; Frånberg J; Svensson AI; Laudon H; Olsson F; Winblad B; Liu F; Näslund J; Lundkvist J; Karlström H
    J Biol Chem; 2010 Mar; 285(12):8527-36. PubMed ID: 20106965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.